Multicentre, Double-Blind, Randomised, Parallel Group, Placebo Controlled, Phase 3 Study of the Efficacy and Safety of Quetiapine Fumarate and Paroxetine as Monotherapy in Adult Patients With Bipolar Depression for 8 Weeks and Quetiapine in Continuation (Abbreviated)
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2014
At a glance
- Drugs Quetiapine (Primary) ; Paroxetine
- Indications Bipolar disorders; Bipolar I disorders; Bipolar II disorders
- Focus Registrational; Therapeutic Use
- Acronyms EMBOLDEN-II
- 26 Feb 2010 Results were published in the Journal of Clinical Psychiatry.
- 03 Sep 2008 Results were presented at ECNP 2008.
- 02 Nov 2007 Status change from in progress to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History